JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB113077

Anti-PHD1/prolyl hydroxylase antibody [EPR2746]

4

(2 Reviews)

|

(11 Publications)

Rabbit Recombinant Monoclonal PHD1/prolyl hydroxylase antibody. Suitable for IHC-P, WB, ICC/IF, Flow Cyt (Intra) and reacts with Mouse, Rat, Human samples. Cited in 11 publications.

View Alternative Names

EIT6, EGLN2, Prolyl hydroxylase EGLN2, Egl nine homolog 2, Estrogen-induced tag 6, HPH-3, Hypoxia-inducible factor prolyl hydroxylase 1, Prolyl hydroxylase domain-containing protein 1, EIT-6, HIF-PH1, HIF-prolyl hydroxylase 1, HPH-1, PHD1

9 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PHD1/prolyl hydroxylase antibody [EPR2746] (AB113077)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PHD1/prolyl hydroxylase antibody [EPR2746] (AB113077)

ab113077, at a 1/100 dilution, staining PHD1/prolyl hydroxylase in paraffin-embedded Human lung carcinoma tissue by Immunohistochemistry.

This image was generated using the unpurified version of the product.

Heat mediated antigen retrieval was performed before commencing with IHC staining protocol.

Immunocytochemistry/ Immunofluorescence - Anti-PHD1/prolyl hydroxylase antibody [EPR2746] (AB113077)
  • ICC/IF

Lab

Immunocytochemistry/ Immunofluorescence - Anti-PHD1/prolyl hydroxylase antibody [EPR2746] (AB113077)

Immunocytochemistry/ Immunofluorescence analysis of HeLa (human cervix adenocarcinoma epithelial cell) cells labeling PHD1/prolyl hydroxylase with purified ab113077 at 1/50 dilution (5 μg/mL). Cells were fixed in 4% Paraformaldehyde and permeabilized with 0.1% tritonX-100. Cells were counterstained with ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) 1/200 (2.5 μg/mL). Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) was used as the secondary antibody at 1/1000 (2 μg/mL) dilution. DAPI (blue) was used as nuclear counterstain. ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) 1/200 (2.5 μg/mL) was used as the secondary antibody only control.

Flow Cytometry (Intracellular) - Anti-PHD1/prolyl hydroxylase antibody [EPR2746] (AB113077)
  • Flow Cyt (Intra)

Unknown

Flow Cytometry (Intracellular) - Anti-PHD1/prolyl hydroxylase antibody [EPR2746] (AB113077)

Intracellular Flow Cytometry analysis of HeLa (Human cervix adenocarcinoma epithelial cell) cells labeling PHD1/prolyl hydroxylase with Purified ab113077 at 1/30 dilution (10μg/ml) (red). Cells were fixed with 4% Paraformaldehyde. A Goat anti rabbit IgG (Alexa Fluorr® 488, ab150077) secondary antibody was used at 1/2000. Isotype control - Rabbit monoclonal IgG (Black). Unlabeled control - Cell without incubation with primary antibody and secondary antibody (Blue).

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PHD1/prolyl hydroxylase antibody [EPR2746] (AB113077)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PHD1/prolyl hydroxylase antibody [EPR2746] (AB113077)

ab113077, at a 1/100 dilution, staining PHD1/prolyl hydroxylase in paraffin-embedded Human breast carcinoma tissue by Immunohistochemistry.

This image was generated using the unpurified version of the product.

Heat mediated antigen retrieval was performed before commencing with IHC staining protocol.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PHD1/prolyl hydroxylase antibody [EPR2746] (AB113077)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PHD1/prolyl hydroxylase antibody [EPR2746] (AB113077)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Human breast cancer tissue sections labeling PHD1/prolyl hydroxylase with Purified ab113077 at 1 : 50 dilution (5.14 μg/ml). Heat mediated antigen retrieval was performed using ab93684 (Tris/EDTA buffer, pH 9.0). ImmunoHistoProbe one step HRP Polymer (ready to use)was used as the secondary antibody. Negative control : PBS instead of the primary antibody. Hematoxylin was used as a counterstain.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PHD1/prolyl hydroxylase antibody [EPR2746] (AB113077)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PHD1/prolyl hydroxylase antibody [EPR2746] (AB113077)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Rat spleen tissue sections labeling PHD1/prolyl hydroxylase with Purified ab113077 at 1 : 50 dilution (5.14 μg/ml). Heat mediated antigen retrieval was performed using ab93684 (Tris/EDTA buffer, pH 9.0). ImmunoHistoProbe one step HRP Polymer (ready to use)was used as the secondary antibody. Negative control : PBS instead of the primary antibody. Hematoxylin was used as a counterstain.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PHD1/prolyl hydroxylase antibody [EPR2746] (AB113077)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PHD1/prolyl hydroxylase antibody [EPR2746] (AB113077)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Mouse testis tissue sections labeling PHD1/prolyl hydroxylase with Purified ab113077 at 1 : 50 dilution (5.14 μg/ml). Heat mediated antigen retrieval was performed using ab93684 (Tris/EDTA buffer, pH 9.0). ImmunoHistoProbe one step HRP Polymer (ready to use)was used as the secondary antibody. Negative control : PBS instead of the primary antibody. Hematoxylin was used as a counterstain.

Western blot - Anti-PHD1/prolyl hydroxylase antibody [EPR2746] (AB113077)
  • WB

Unknown

Western blot - Anti-PHD1/prolyl hydroxylase antibody [EPR2746] (AB113077)

This image was generated using the unpurified version of the product.

All lanes:

Western blot - Anti-PHD1/prolyl hydroxylase antibody [EPR2746] (ab113077) at 1/1000 dilution

Lane 1:

A549 cell lysates at 10 µg

Lane 2:

HeLa cell lysates at 10 µg

Lane 3:

MCF-7 cell lysates at 10 µg

Predicted band size: 44 kDa

false

Western blot - Anti-PHD1/prolyl hydroxylase antibody [EPR2746] (AB113077)
  • WB

Lab

Western blot - Anti-PHD1/prolyl hydroxylase antibody [EPR2746] (AB113077)

All lanes:

Western blot - Anti-PHD1/prolyl hydroxylase antibody [EPR2746] (ab113077) at 1/1000 dilution

Lane 1:

MCF7 (Human breast adenocarcinoma epithelial cell) whole cell lysates at 20 µg

Lane 2:

Human fetal heart lysates at 20 µg

Lane 3:

Mouse brain lysates at 20 µg

Lane 4:

Mouse heart lysates at 20 µg

Lane 5:

Rat brain lysates at 20 µg

Lane 6:

Rat heart lysates at 20 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution

Predicted band size: 44 kDa

Observed band size: 40 kDa,43 kDa

false

  • Carrier free

    Anti-PHD1/prolyl hydroxylase antibody [EPR2746] - BSA and Azide free

  • 519 Alexa Fluor® 488

    Alexa Fluor® 488 Anti-PHD1/prolyl hydroxylase antibody [EPR2746]

  • 665 Alexa Fluor® 647

    Alexa Fluor® 647 Anti-PHD1/prolyl hydroxylase antibody [EPR2746]

  • 565 Alexa Fluor® 555

    Alexa Fluor® 555 Anti-PHD1/prolyl hydroxylase antibody [EPR2746]

  • 617 Alexa Fluor® 594

    Alexa Fluor® 594 Anti-PHD1/prolyl hydroxylase antibody [EPR2746]

  • 578 PE

    PE Anti-PHD1/prolyl hydroxylase antibody [EPR2746]

  • 660 APC

    APC Anti-PHD1/prolyl hydroxylase antibody [EPR2746]

  • 775 Alexa Fluor® 750

    Alexa Fluor® 750 Anti-PHD1/prolyl hydroxylase antibody [EPR2746]

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR2746

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Rat, Human

Applications

IHC-P, Flow Cyt (Intra), ICC/IF, WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

style
left-column

Alternative Products

Primary Antibodies

AB82884

Anti-PHD1/prolyl hydroxylase antibody [PHD112/G7]

  • 0
  • 0
Primary Antibodies

AB108980

Anti-PHD1/prolyl hydroxylase antibody [EPR2745]

RabMAb|Recombinant|Trial Size

Immunocytochemistry/ Immunofluorescence - Anti-PHD1/prolyl hydroxylase antibody [EPR2745] (AB108980)

  • 2
  • 1

Complementary Products

Primary Antibodies

AB184714

Anti-PHD3 antibody [EPR17869]

RabMAb|Recombinant

Immunocytochemistry/ Immunofluorescence - Anti-PHD3 antibody [EPR17869] (AB184714)

  • 0
  • 0
Primary Antibodies

AB133630

Anti-PHD2 / prolyl hydroxylase antibody [EPR3660(B)(2)]

RabMAb|Recombinant|KO Validated

Immunoprecipitation - Anti-PHD2 / prolyl hydroxylase antibody [EPR3660(B)(2)] (AB133630)

  • 4
  • 1
Primary Antibodies

AB179483

Anti-HIF-1 alpha antibody [EPR16897]

RabMAb|Advanced Validation|Recombinant|KO Validated

Immunocytochemistry/ Immunofluorescence - Anti-HIF-1 alpha antibody [EPR16897] (AB179483)

  • 4
  • 9
Primary Antibodies

AB15580

Anti-Ki67 antibody

BOND RX™ Validated|KO Validated

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Ki67 antibody (AB15580)

  • 5
  • 230
style
left-column

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/50", "IHCP-species-notes": "<p><strong>For unpurified use at 1/100 - 1/250.</strong></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/50 - 1/100", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/30", "FlowCytIntra-species-notes": "<p></p>" }, "Mouse": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/50", "IHCP-species-notes": "<p><strong>For unpurified use at 1/100 - 1/250.</strong></p>", "WB-species-checked": "guaranteed", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "FlowCytIntra-species-checked": "guaranteed", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "" }, "Rat": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/50", "IHCP-species-notes": "<p><strong>For unpurified use at 1/100 - 1/250.</strong></p>", "WB-species-checked": "guaranteed", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "FlowCytIntra-species-checked": "guaranteed", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "" } } }
style
left-column

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

style
left-column

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Storage information
Stable for 12 months at -20°C
style
left-column

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Prolyl hydroxylase 1 (PHD1) also known as EGLN2 is an enzyme that hydroxylates specific proline residues within target proteins. This process of prolyl hydroxylation is critical for regulating protein stability. PHD1 shares structural similarities with other members of the 2-oxoglutarate-dependent dioxygenase family and includes a conserved iron-binding motif essential for its enzymatic activity. PHD1 has a molecular mass of approximately 46 kDa and is expressed in a variety of tissues with notable presence in skeletal muscle heart and the liver.
Biological function summary

PHD1 modulates the stability of the hypoxia-inducible factor (HIF) proteins which are key regulators of oxygen homeostasis in the cell. Under normoxic conditions PHD1 hydroxylates specific proline residues on HIF-alpha marking it for degradation via the ubiquitin-proteasome pathway. This enzyme does not function as part of a larger protein complex but it plays a pivotal role in determining the cellular response to oxygen levels. Additionally PHD1 expression affects the metabolic adaptation processes and energy expenditure in cells.

Pathways

PHD1 plays a role in the cellular response to hypoxia and is integral to the HIF signaling pathway. It interacts directly with HIF-alpha subunits mediating their degradation under normal oxygen conditions to ensure HIF activity remains inhibited. Additionally PHD1 is indirectly involved in modulating the angiogenesis pathway as it influences the availability of HIF-related transcription factors which promote transcription of vascular endothelial growth factor (VEGF) under low oxygen conditions. The interplay between PHD1 PHD2 and PHD3 ensures a fine-tuned regulation of the HIF pathway based on oxygen availability.

PHD1 has links to cancer progression and ischemic conditions. The enzyme’s activity is often altered in response to the aberrant hypoxic signaling found within tumors impacting cellular proliferation and survival. In ischemic conditions reduced PHD1 activity leads to stabilization of HIF proteins and adaptation responses aimed at tissue survival. Mutations or dysregulation in PHD1 expression have been observed in metabolic syndromes suggesting potential therapeutic targets. Through its control over hypoxia-related proteins PHD1 also interacts with von Hippel-Lindau (VHL) protein which is part of the E3 ubiquitin ligase complex important for HIF-alpha degradation.
style
left-column
style
left-column

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:
style
left-column

Target data

Prolyl hydroxylase that mediates hydroxylation of proline residues in target proteins, such as ATF4, IKBKB, CEP192 and HIF1A (PubMed : 11595184, PubMed : 12039559, PubMed : 15925519, PubMed : 16509823, PubMed : 17114296, PubMed : 23932902). Target proteins are preferentially recognized via a LXXLAP motif (PubMed : 11595184, PubMed : 12039559, PubMed : 15925519). Cellular oxygen sensor that catalyzes, under normoxic conditions, the post-translational formation of 4-hydroxyproline in hypoxia-inducible factor (HIF) alpha proteins (PubMed : 11595184, PubMed : 12039559, PubMed : 12181324, PubMed : 15925519, PubMed : 19339211). Hydroxylates a specific proline found in each of the oxygen-dependent degradation (ODD) domains (N-terminal, NODD, and C-terminal, CODD) of HIF1A (PubMed : 11595184, PubMed : 12039559, PubMed : 12181324, PubMed : 15925519). Also hydroxylates HIF2A (PubMed : 11595184, PubMed : 12039559, PubMed : 15925519). Has a preference for the CODD site for both HIF1A and HIF2A (PubMed : 11595184, PubMed : 12039559, PubMed : 15925519). Hydroxylated HIFs are then targeted for proteasomal degradation via the von Hippel-Lindau ubiquitination complex (PubMed : 11595184, PubMed : 12039559, PubMed : 15925519). Under hypoxic conditions, the hydroxylation reaction is attenuated allowing HIFs to escape degradation resulting in their translocation to the nucleus, heterodimerization with HIF1B, and increased expression of hypoxy-inducible genes (PubMed : 11595184, PubMed : 12039559, PubMed : 15925519). EGLN2 is involved in regulating hypoxia tolerance and apoptosis in cardiac and skeletal muscle (PubMed : 11595184, PubMed : 12039559, PubMed : 15925519). Also regulates susceptibility to normoxic oxidative neuronal death (PubMed : 11595184, PubMed : 12039559, PubMed : 15925519). Links oxygen sensing to cell cycle and primary cilia formation by hydroxylating the critical centrosome component CEP192 which promotes its ubiquitination and subsequent proteasomal degradation (PubMed : 23932902). Hydroxylates IKBKB, mediating NF-kappa-B activation in hypoxic conditions (PubMed : 17114296). Also mediates hydroxylation of ATF4, leading to decreased protein stability of ATF4 (By similarity).
See full target information EGLN2
style
left-column

Publications (11)

Recent publications for all applications. Explore the full list and refine your search

The Journal of clinical investigation 135: PubMed39621585

2024

Postischemic inactivation of HIF prolyl hydroxylases in endothelium promotes maladaptive kidney repair by inducing glycolysis.

Applications

Unspecified application

Species

Unspecified reactive species

Ratnakar Tiwari,Rajni Sharma,Ganeshkumar Rajendran,Gabriella S Borkowski,Si Young An,Michael Schonfeld,James O'Sullivan,Matthew J Schipma,Yalu Zhou,Guillaume Courbon,Benjamin R Thomson,Valentin David,Susan E Quaggin,Edward B Thorp,Navdeep S Chandel,Pinelopi P Kapitsinou

Journal of nanobiotechnology 22:479 PubMed39134988

2024

Oral administration of Robinia pseudoacacia L. flower exosome-like nanoparticles attenuates gastric and small intestinal mucosal ferroptosis caused by hypoxia through inhibiting HIF-1α- and HIF-2α-mediated lipid peroxidation.

Applications

Unspecified application

Species

Unspecified reactive species

Dezhi Wang,Heng Zhang,Xingchen Liao,Jun Li,Jie Zeng,Yilin Wang,Mingjie Zhang,Xianzong Ma,Xin Wang,Fangli Ren,Yinyin Wang,Meng Li,Junfeng Xu,Peng Jin,Jianqiu Sheng

Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11:e2308701 PubMed38460168

2024

Framework Nucleic Acids-Based VEGF Signaling Activating System for Angiogenesis: A Dual Stimulation Strategy.

Applications

Unspecified application

Species

Unspecified reactive species

Yichen Ge,Qingxuan Wang,Yangxue Yao,Qin Xin,Jiafei Sun,Wen Chen,Yunfeng Lin,Xiaoxiao Cai

Cell death & disease 14:617 PubMed37730658

2023

Hypoxia-induced ALDH3A1 promotes the proliferation of non-small-cell lung cancer by regulating energy metabolism reprogramming.

Applications

Unspecified application

Species

Unspecified reactive species

Yang Chen,Hongfei Yan,Lirong Yan,Ximing Wang,Xiaofang Che,Kezuo Hou,Yi Yang,Xuena Li,Yaming Li,Ye Zhang,Xuejun Hu

Cell journal 25:264-272 PubMed37210647

2023

Down-Regulation of CEND1 Expression Contributes to The Progression and Temozolomide Resistance of Glioma.

Applications

Unspecified application

Species

Unspecified reactive species

Zhou Houjun,Bai Peng

Nature genetics 54:1721-1735 PubMed36347944

2022

Histone H3 proline 16 hydroxylation regulates mammalian gene expression.

Applications

Unspecified application

Species

Unspecified reactive species

Xijuan Liu,Jun Wang,Joshua A Boyer,Weida Gong,Shuai Zhao,Ling Xie,Qiong Wu,Cheng Zhang,Kanishk Jain,Yiran Guo,Javier Rodriguez,Mingjie Li,Hidetaka Uryu,Chengheng Liao,Lianxin Hu,Jin Zhou,Xiaobing Shi,Yi-Hsuan Tsai,Qin Yan,Weibo Luo,Xian Chen,Brian D Strahl,Alex von Kriegsheim,Qi Zhang,Gang Greg Wang,Albert S Baldwin,Qing Zhang

Scientific reports 12:74 PubMed34996938

2022

Enhanced glucose metabolism through activation of HIF-1α covers the energy demand in a rat embryonic heart primordium after heartbeat initiation.

Applications

Unspecified application

Species

Unspecified reactive species

Tatsuya Sato,Nobutoshi Ichise,Takeshi Kobayashi,Hiroyori Fusagawa,Hiroya Yamazaki,Taiki Kudo,Noritsugu Tohse

International journal of molecular sciences 22: PubMed34205318

2021

LRP5 Regulates HIF-1α Stability via Interaction with PHD2 in Ischemic Myocardium.

Applications

Unspecified application

Species

Unspecified reactive species

Sujin Ju,Leejin Lim,Kwanhwan Wi,Changwon Park,Young-Jae Ki,Dong-Hyun Choi,Heesang Song

The Journal of clinical investigation 131: PubMed33792566

2021

Hypoxia-inducible factor-1α-dependent induction of miR122 enhances hepatic ischemia tolerance.

Applications

Unspecified application

Species

Unspecified reactive species

Cynthia Ju,Meng Wang,Eunyoung Tak,Boyun Kim,Christoph Emontzpohl,Yang Yang,Xiaoyi Yuan,Huban Kutay,Yafen Liang,David R Hall,Wasim A Dar,J Steve Bynon,Peter Carmeliet,Kalpana Ghoshal,Holger K Eltzschig

International journal of molecular sciences 21: PubMed32708433

2020

Loss of miR-145-5p Causes Ceruloplasmin Interference with PHD-Iron Axis and HIF-2α Stabilization in Lung Adenocarcinoma-Mediated Angiogenesis.

Applications

Unspecified application

Species

Unspecified reactive species

Ying-Ming Tsai,Kuan-Li Wu,Yung-Yun Chang,Wei-An Chang,Yung-Chi Huang,Shu-Fang Jian,Pei-Hsun Tsai,Yi-Shiuan Lin,Inn-Wen Chong,Jen-Yu Hung,Ya-Ling Hsu
View all publications
style
left-column
style
left-column
style
right-column

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com